Top Markets
Coin of the day
StemCell Institute Inc. StemCell Institute Inc.

StemCell Institute Inc.

7096
Rank in Stocks #25357
StemCell Institute Inc. provides specialized stem cell banking services... StemCell Institute Inc. provides specialized stem cell banking services throughout Japan. In addition to its core preservation activities, the company is deeply involved in the research and development of medical therapies that utilize stem cells, and it also offers banking solutions for blood vessel cells. Founded in 1999, StemCell Institute Inc. is headquartered in Tokyo, Japan, and operates as a subsidiary of Trim Medical Holdings Inc.
Share Price
$4.97
Market Cap
$50.06M
Change (1 day)
-1.68%
Change (1 year)
-28.05%
Country
JP
Trade StemCell Institute Inc. (7096)

Category

Operating Margin for StemCell Institute Inc. (7096)
Operating Margin as of 2026 TTM: 0.00%
According to StemCell Institute Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for StemCell Institute Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
-149.01% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.